COVID-19: UK approves Pfizer-BioNTech vaccine ahead of US, EU

0
23

 

By Aiyeku Timothy

The UK has approved the use of Pfizer Inc. and BioNTech SE as Covid-19 vaccine as it would be available in Britain from next week, making them the first western country to achieve this feat as the

The approval of the vaccine is done ahead of the decisions that would be made in the US and European Union, following the approval by emergency authorities for the deployment of a vaccine that’s expected to play a significant role in the global effort to halt the coronavirus.

In November, Pfizer and its German partner had assured that the shot, relying on novel technology called messenger RNA, was 95% effective in a final analysis of clinical-trial data.

The UK’s move to quickly approve the vaccine is to protect its citizens in the wake of the surge of the virus after doctors across the country were put on standby for a possible rollout.

About 60,000 deaths have been recorded by in Britain as a result of the pandemic while the world is still counting loses from the outbreak.

Until an official approval is given by the World Health Organization (WHO) there is yet to be a cure for the coronavirus pandemic that pout a halt to the world’s activates for months.

LEAVE A REPLY

Please enter your comment!
Please enter your name here